DI
TEVA icon

DFPG Investments’s Teva Pharmaceuticals TEVA Stock Holding History

DFPG Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$111K Hold
10,170
– – 0.01% 612
2023
Q3 		$89.2K Sell
10,170
-50
-0.5% -$466 0.01% 567
2023
Q2 		$87.5K Buy
10,220
+50
+0.5% +$405 0.01% 563
2023
Q1 		$90K Hold
10,170
– – 0.01% 505
2022
Q4 		$113K Buy
+10,170
New +$88.7K 0.02% 424
2020
Q3 		– Sell
-28,794
Closed -$323K – 190
2020
Q2 		$323K Sell
28,794
-72,881
-72% -$824K 0.2% 114
2020
Q1 		$1.02M Buy
101,675
+91,675
+917% +$939K 0.76% 33
2019
Q4 		$105K Sell
10,000
-400
-4% -$3.57K 0.07% 153
2019
Q3 		$68K Buy
+10,400
New +$79.7K 0.06% 155

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

DFPG Investments's TEVA Position: Q4 2023 in Review

DFPG Investments held its Teva Pharmaceuticals (TEVA) position steady in Q4 2023 at 10,170 shares worth $111K. The position accounts for 0.01% of the portfolio, ranked #612.

DFPG Investments first reported a position in TEVA in Q3 2019 and has held it in 9 quarters since. The position peaked at $1.02M in Q1 2020. 447 funds tracked by Wall St. Rank hold TEVA as of Q4 2023.

  • DFPG Investments held 10,170 shares of Teva Pharmaceuticals worth $111K as of Q4 2023.
  • DFPG Investments left its Teva Pharmaceuticals share count unchanged in Q4 2023.
  • Teva Pharmaceuticals made up 0.01% of DFPG Investments's portfolio in Q4 2023, its #612 holding.
  • DFPG Investments first reported a position in Teva Pharmaceuticals in Q3 2019 and has held it in 9 quarters since.
  • DFPG Investments's Teva Pharmaceuticals position peaked at $1.02M in Q1 2020.
  • 447 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2023.

Based on DFPG Investments's 13F filing for Q4 2023, filed 10 Jan 2024.